Recent developments on coronavirus main protease/3C like protease inhibitors

Area of Science:

• Virology
• Drug Discovery
• Biochemistry

Background:

• Recurring novel human coronavirus infections, including SARS, highlight the need for effective antiviral strategies.
• Coronaviruses pose a significant public health threat, necessitating continuous research and development of countermeasures.
• The rapid growth of coronavirus research has expanded the arsenal against this virus family.

Purpose of the Study:

• To review progress in drug discovery methods for coronavirus inhibitors.
• To summarize existing and potential inhibitors targeting coronavirus 3C-like proteases (3Cl).
• To provide an overview of advancements in antiviral drug development against coronaviruses.

Main Methods:

• Literature review of drug discovery approaches.
• Analysis of patented inhibitors against coronavirus 3Cl.
• Summary of virtual screening, natural product isolation, and structure-assisted rational drug design.

Main Results:

• Coronavirus 3C-like proteases (3Cl) are a primary target for antiviral drug development.
• Various drug discovery methods have yielded promising inhibitors with clinical potential.
• Significant progress has been made in identifying and developing inhibitors against coronavirus 3Cl.

Conclusions:

• Targeting coronavirus 3Cl is a viable strategy for developing effective antiviral therapies.
• Continued research into drug discovery methods and inhibitor development is crucial for combating coronavirus infections.
• The reviewed approaches offer a foundation for future development of novel antiviral drugs.